ZypAdhera ® (olanzapine pamoate monohydrate)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: ZypAdhera Summary of Product Characteristics (SmPC)

ZypAdhera® (olanzapine pamoate): Latex

ZypAdhera vial components (including the diluent for reconstitution) do not contain natural rubber latex or dry natural rubber.

Further Information

The stoppers are made of a synthetic rubber.1

ZypAdhera is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of ZypAdhera.2

The excipients are:2


  • None


  • Carmellose sodium

  • Mannitol

  • Polysorbate 80

  • Water for injections

  • Hydrochloric acid (for pH adjustment)

  • Sodium hydroxide (for pH adjustment)


1. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

2. ZypAdhera [summary of product characteristics] Eli Lilly Netherland B.V., The Netherlands.

Date of Last Review: February 13, 2020

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request